“And people are dying. About 20% of all our patients together are actually dying before they can get CAR-T,” said Krina Patel, director of the myeloma cell therapy program at MD Anderson.
Preparing Patients for CAR T-Cell Therapy With Confidence
Preparing Patients for CAR T-Cell Therapy With Confidence
The Unlikely Story of Cancer's Most Promising New Therapy - Scientific American
CAR T Cell Therapy Cancer Support Community
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Multiple myeloma patients await MSAC verdict on CAR T-cell therapy to manage blood cancer - ABC News
Improving immunotherapy for advanced prostate cancer
Death triggers pause of 2seventy CAR-T cell therapy AML trial
Surrey man goes to China for experimental cancer treatment